The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Global Astragalus Injection Market Growth 2025-2031
US$ 3,660.00
The global Astragalus Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Astra...
September 2025
86 pages
Global Chymotrypsin for Injection Market Growth 2025-2031
US$ 3,660.00
The global Chymotrypsin for Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for...
September 2025
77 pages
Middle East Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product (Traditional API, HP-API, Biologics) By Synthesis (Synthetic, Biotech), By Drug, By Application, By Workflow, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The Middle East active pharmaceutical ingredient CDMO market size was estimated at USD 7.23 billion in 2024 and is projected to reach USD 11.64 billion by 2033, growing at a CAGR...
September 2025
150 pages
Middle East Pharmaceutical Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Type, By Product, By Service, By Workflow, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Middle East Pharmaceutical Contract Development & Manufacturing Organization Market The Middle East pharmaceutical contract development and manufacturing organization market size was estimated at USD...
September 2025
120 pages
Pharmaceutical Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Type (Small Molecule, Large Molecule), By Product (API, Drug), By Services, By Workflow, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Pharmaceutical Contract Development And Manufacturing Organization Market The global pharmaceutical contract development and manufacturing organization market size was estimated at USD 155.5 billion i...
September 2025
250 pages
Longevity Therapeutics Market - 2023-2033
US$ 2,999.00
The Longevity Therapeutics Market was valued at US$ 21.74 Billion in 2023 and is anticipated to reach US$ 43.72 Billion by 2033, at a CAGR of 0.078 from 2026 to 2032. The report delivers in-depth insi...
September 2025
207 pages
Large Molecule Drug Substance CDMO Market Size, Share & Trends Analysis Report By Product, By Service (Contract Manufacturing, Contract Development), By Source, By End-use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Large Molecule Drug Substance CDMO Market The global large molecule drug substance CDMO market size was estimated at USD 52.02 billion in 2024 and is projected to reach USD 101.41 billion by 2033, gro...
September 2025
120 pages
U.S. Large Molecule Drug Substance CDMO Market Size, Share & Trends Analysis Report By Product (Biologics, Biosimilar), By Service (Contract Manufacturing, Contract Development), By Source, By End Use, By Country, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The U.S. large molecule drug substance CDMO market size was estimated at USD 12.22 billion in 2024 and is projected to reach USD 22.56 billion by 2033, growing at a CAGR of 7.06%...
September 2025
120 pages
Septicemia Antibiotics Market Forecasts to 2032 – Global Analysis By Drug Class (Cephalosporins, Carbapenems, Glycopeptides, Penicillins, Aminoglycosides, and Other Drug Classes), Pathogen Type, Route of Administration, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Septicemia Antibiotics Market is accounted for $2.73 billion in 2025 and is expected to reach $3.82 billion by 2032 growing at a CAGR of 4.9% during the foreca...
September 2025
200 pages
Pharmacy Benefit Management Market Size, Share & Trends Analysis Report By Business Model (Standalone PBM, Health Insurance Providers, Retail Pharmacy), By End Use (Commercial, Federal), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Pharmacy Benefit Management Market The global pharmacy benefit management market size was estimated at USD 747.08 billion in 2024 and is projected to reach USD 1,726.27 billion by 2033, growing at a C...
September 2025
150 pages
Physiological Saline Market Size, Share & Trends Analysis Report By Product (Intravenous (IV) Saline Solutions, Nasal Irrigation Solutions), By Container, By Volume, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Physiological Saline Market The global physiological saline market size was estimated at USD 5.24 billion in 2024 and is projected to reach USD 9.54 billion by 2033, growing at a CAGR of 6.97% from 20...
September 2025
120 pages
Global Neurotherapeutics Market - 2024-2033
US$ 2,999.00
The Global Neurotherapeutics Market was valued at US$ 7.28Billion in 2024 and is anticipated to reach US$ 11.10Billion by 2033, at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insig...
September 2025
218 pages
Liver Disease Treatment Market - 2024-2033
US$ 2,999.00
The Liver Disease Treatment Market was valued at US$ 22.70 billion in 2024 and is anticipated to reach US$ 40.94 billion by 2033, at a CAGR of 0.068 from 2026 to 2032. The report delivers in-depth ins...
September 2025
218 pages
Localized Scleroderma Market 2026
US$ 2,999.00
The Localized Scleroderma Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
September 2025
200 pages
Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Type (Small Molecule, Large Molecule), By Product (Pharmaceutical, Medical Devices), By Service, By Workflow, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Healthcare Contract Development And Manufacturing Organization Market The global healthcare contract development and manufacturing organization market size was estimated at USD 278.1 billion in 2024 a...
September 2025
120 pages
Middle East Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Type (Small Molecule, Large Molecule), By Product, By Service, By Workflow (Clinical, Commercial), By Therapeutic Area, By End-use, By Country And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Middle East Healthcare Contract Development And Manufacturing Organization Market The Middle East healthcare contract development and manufacturing organization market size was estimated at USD 6.27 b...
September 2025
120 pages
